Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jeanne M. Regnante"'
Autor:
Jeanne M. Regnante, Nicole Richie, Lola Fashoyin-Aje, Laura Lee Hall, Quita Highsmith, J'Aimee Louis, Kenneth Turner, Spencer Hoover, Simon Craddock Lee, Evelyn González, Erin Williams, Homer Adams, III, Coleman Obasaju, Ify Sargeant, Jovonni Spinner, Christopher Reddick, Marianne Gandee, Madeline Geday, Julie Dang, Rayneisha Watson, Moon S. Chen, Jr.
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials. Me
Externí odkaz:
https://doaj.org/article/bcf3080c37f64eaa96be3f2b6b05c407
Autor:
Patricia Doykos, Evelyn Gonzalez, Karen M. Winkfield, Karen M. Freund, Ellen Miller-Sonet, Jeanne M. Regnante
Publikováno v:
JCO Oncology Practice. 17:e278-e293
PURPOSE: Cancer disparities persist among medically underserved populations despite widespread efforts to address them. We describe the development of a framework for addressing cancer care disparities across the cancer care continuum (CCC), guided b
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:A024-A024
By modernizing cancer journal roles and editorial policy there may be greater rigor, biological understanding, scientific generalizability, reproducibility, transparency, and inclusion in cancer research. A path to identifying, addressing and correct
Autor:
Khaled Alamri, Molly L. Aldridge, Larry Alphs, Barbara E. Bierer, Eric P. Borrelli, Jaclyn L.F. Bosco, Nicholas Brooke, Emily S. Brouwer, Aisling R. Caffrey, Alicyn Campbell, Timothy S. Carey, Wendy Camelo Castillo, John Chaplin, Jennifer B. Christian, Thomas W. Concannon, Catherine Copley-Merriman, Kourtney Davis, Robert S. Epstein, Nicolle M. Gatto, Cynthia J. Girman, Rolf H.H. Groenwold, Cynthia Grossman, Kristen A. Hahn, Anne Marie Hamior, Katherine E. Harris, Ehab Hasan, Austin R. Horn, Phyo T. Htoo, Kristy Iglay, Michele Jonsson Funk, Sylvia Baedorf Kassis, Bray Patrick Lake, Suzanne N. Landi, Craig Lipset, Vincent Lo Re, Jennifer L. Lund, Kenneth Man, Elizabeth Manning, Leah McGrath, Michelle Medeiros, Marilyn A. Metcalf, Margaret Mordin, Mary Stober Murray, Nabil Natafgi, Catherine A. Panozzo, Jeanne M. Pimenta, Sudha R. Raman, Jeanne M. Regnante, Nicole A. Richie, Mary E. Ritchey, Jamie Roberts, Ify Sargeant, Roslyn F. Schneider, Suzanne Schrandt, Joe V. Selby, Soko Setoguchi, Ju-Young (Judy) Shin, Joanna Siegel, Fabian Somers, Komathi Stem, Til Stürmer, Elizabeth A. Suarez, J. Russell Teagarden, Kevin E. Thorpe, Lina Titievsky, Andrea B. Troxel, Priscilla Velentgas, Cunlin Wang, Jenna Wong, Stephen Yates, Guy Yeoman, Wei Zhou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfe115e0e1fb3d212f5d186895ac3cf3
https://doi.org/10.1016/b978-0-12-817663-4.01002-3
https://doi.org/10.1016/b978-0-12-817663-4.01002-3
Autor:
Bray Patrick Lake, Nicholas Brooke, Jamie Roberts, Cynthia Grossman, Anne Marie Hamior, Elizabeth Manning, Roslyn F. Schneider, Fabian Somers, Nicole Richie, Stephen Yates, Alicyn Campbell, Sylvia Baedorf Kassis, Jeanne M. Regnante, Barbara E. Bierer, Guy Yeoman, Suzanne Schrandt, Ify Sargeant, Mary Stober Murray, Marilyn A. Metcalf, Craig Lipset
In this Chapter, Patient Voice in Clinical Trial Programs in Industry, we argue that the Life Sciences industry must adapt if they are to succeed and make medicines with (rather than just for) patients. Those companies able to deliver medicines and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e570bffeaf1266249cced0186aa21eb
https://doi.org/10.1016/b978-0-12-817663-4.00026-x
https://doi.org/10.1016/b978-0-12-817663-4.00026-x
Autor:
Jeanne M. Regnante, Lola Fashoyin-Aje, Ellen Miller Sonet, Quita Highsmith, Melissa Gonzales, Sandra Amaro, Amy Davis, Mary Stober Murray, Maimah Karmo, Barbara Bierer
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-084
Development of medicines and vaccines for COVID-19 amplified the need for all US communities to participate in research. This recognition spurred interest in adopting inclusive and equitable research practices across industry and the clinical researc
Autor:
Jeanne M. Regnante, Upal Basu Roy, Catina O'Leary, Linda M. Fleisher, Diane W. Webb, Linda Wenger, Andrea Ferris, Robert Winn
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-064
In the United States, communities at risk of developing lung cancer include rural populations, low socioeconomic status (SES) and the under-insured, immigrants, aged populations, racial and ethnic minority groups, and LGBTQIA communities. Many of the
Autor:
Moon S. Chen, Ify Sargeant, Marianne Gandee, Nicole Richie, Julie H.T. Dang, Christopher Reddick, J'Aimee A. Louis, Homer Adams, Jovonni Spinner, Kenneth Turner, Rayneisha Watson, Quita Highsmith, Coleman K. Obasaju, Madeline Geday, Evelyn Gonzalez, Lola Fashoyin-Aje, Spencer C. Hoover, Jeanne M. Regnante, Simon J. Craddock Lee, Laura Lee Hall, Erin Fenske Williams
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials. Me
Autor:
Lorna H. McNeill, Nestor F. Esnaola, Kenneth Turner, Keerthi Gogineni, Moon S. Chen, Coleman K. Obasaju, Upal Basu Roy, Lola Fashoyin-Aje, Daniel G. Petereit, Olatunji B. Alese, Homer Adams, Luther T. Clark, Quita Highsmith, Simon J. Craddock Lee, Michelle Vichnin, Laura Lee Hall, Erin L Williams, Marvella E. Ford, Julie H.T. Dang, Evelyn Gonzalez, Ify Sargeant, Nicole Richie, Spencer C. Hoover, Jeanne M. Regnante
Publikováno v:
Journal of oncology practice. 15(4)
PURPOSE: Participation of racial and ethnic minority groups (REMGs) in cancer trials is disproportionately low despite a high prevalence of certain cancers in REMG populations. We aimed to identify notable practices used by leading US cancer centers
Autor:
Ola Akinboboye, Brenda Jamerson, Luther T. Clark, Adam B. Polis, Mary Elmer, Christine Pierre, Millicent Gorham, Gary Puckrein, Jeanne M. Regnante, Ileana L. Piña, Laurence O. Watkins, Cassandra McCullough
Publikováno v:
Current problems in cardiology. 44(5)
Clinical trial results provide the critical evidence base for evaluating the safety and efficacy of new medicines and medical products. Efficacy and safety may differ among population subgroups depending on intrinsic/extrinsic factors, including sex,